Newer insulin 3-5 times cost of older one in India: Study
THE TIMES OF INDIA AUGUST 22, 2019 Globally, one in two people who need insulin, lack access to it due to high prices and poor availability. The problem in India is availability, quality and the huge price differential between newer, second generation (rapid and long acting) insulin and older versions, while developed markets like US have witnessed skyrocketing insulin prices. One of the most comprehensive studies ever done on insulin globally, published in reputed medical journal BMJ, points out the huge differential, saying human insulin is far more affordable than analogue insulin i.e. 1.3-1.9 (human) versus 4.6-9.2 (analogue) days’ wages. (The affordability of insulin is expressed as the number of days wages needed by the lowest paid unskilled government worker to purchase 10 ml insulin from private pharmacies). Analogues (newer versions of insulin) are priced in India three to five times the price of the older versions, and hence unaffordable for a majority of...